Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Gastroenterology
Disease Category: Inflammatory Bowel Disease
Trial Information
A pilot study on the efficacy of a 10-week mind body intervention on quality of life and inflammatory disease markers in patients with Irritable Bowel Syndrome (IBS) and Inflammatory Bowel Disease (IBD)
Irritable Bowel Syndrome (IBS) and Inflammatory Bowel Disease (IBD) Mind Body Group Intervention Study
Subjects needed to take part in a GI Mind Body Interventional study. You may be a good candidate for the 10-week study involving group sessions (relaxation, meditation, and behavioral therapy), questionnaires to track progress throughout the 10-week experience, and blood analysis. Groups will start mid-September and will meet on Wednesdays from 4:00 PM to 5:30 PM at MGH.
There is no payment for participating in this study, but you will be receiving care. The study will pay for parking for necessary visits.
For further information, please contact Nicole Hasheminejad, nhasheminejad@partners.org; or Allison Dassatti, adassatti@partners.org.
General Inclusion Criteria
•Between the ages of 18 and 75
•Have documentation of diagnosis of IBS or IBD.
General Exclusion Criteria
•Cannot currently practice Tai Chi, meditation, or yoga regularly.
•Cannot have recently started psychotherapy
•Must not have duodenal ulcer, gastric ulcer, diverticulitis, GERD, infectious gastroenteritis or acute gastrointestinal process.
•Cannot be taking steroids (exception: prednisone dose ≤ 20mg acceptable).
Nicole Hasheminejad, CRC
Massachusetts General Hospital
55 Fruit Street
Boston, MA 02114
Phone: 617-643-6062
EMail: nhasheminejad@partners.org
View Google Map
If you would like to learn more about participating in this study, please send an e-mail message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these
trials.
